GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Tacrolimus Capsules IP 1mg
C. Tacrolimus Capsules IP 2mg
D. Tacrolimus Capsules IP 5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….0.5mg
Excipients…………………………………..q.s.
Approved colours used in capsule shell.
B. Tacrolimus Capsules IP 1mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….1mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.
C. Tacrolimus Capsules IP 2mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….2mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.
D. Tacrolimus Capsules IP 5mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….5mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A NEPHROLOGIST.
IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.
STORAGE & DOSAGE:
Protect from Light.
Do not refrigerate.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Dosage: As directed by the Nephrologist.
Tacrolimus Capsules IP 1mg Technical Specification:
Product Name: | Tacrolimus Capsules IP 1mg |
Brand Name: | TACROTAJ |
Strength: | 0.5mg, 1mg, 2mg, 5mg |
Dosage Form: | Hard Gelatin Capsules |
Route of Administration: | Via Oral Route |
Packing: | 10s, 30s, 100s, 500s |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
Documents: | COA, MOA, Stability Studies, GMP |
Therapeutic use: | Immunosuppressants |
Indication: | Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may be used with steroids, azathioprine, basiliximab, or mycophenolate mofetil. Tacrolimus belongs to a group of medicines known as immunosuppressive agents. |
Storage: | Store below 30 °C. Protect from Light. Do not refrigerate. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Tacrolimus Capsules IP 1mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Tacrolimus Capsules IP 1mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….1mg
Excipients…………………………………..q.s.
Approved colours used in capsule shell.
THERAPEUTIC INDICATIONS:
Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may be used with steroids, azathioprine, basiliximab, or mycophenolate mofetil. Tacrolimus belongs to a group of medicines known as immunosuppressive agents.
CAUTION & SHEDULE:
CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A Nephrologist.
IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.
STORAGE & DOSAGE:
Storage: Store below 30 °C. Protect from Light. Do not refrigerate.
Read enclosed leaflet before use.
Keep medicine out of reach of children.
Dosage: As directed by the Nephrologist.